Company facts
- Industry
- Real Estate Investment Trusts
- Headquarters
- Boston, Massachusetts
- Most recent report
- 8-K, filed Aug 31, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1037540
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 40
News 8 of 83
Prospectuses and Registrations 8 of 21
- 424B2 Prospectus supplement for an offering Mar 6, 2026
- 424B5 Prospectus supplement for an offering Mar 6, 2026
- S-3ASR Automatic shelf registration Mar 6, 2026
- S-3ASR Automatic shelf registration Mar 6, 2026
- S-8 Registration statement for an employee plan May 24, 2024
- S-3ASR Automatic shelf registration May 17, 2023
- 424B2 Prospectus supplement for an offering May 17, 2023
- 424B5 Prospectus supplement for an offering May 17, 2023
Proxies 8 of 22
- DEFA14A Extra proxy material Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- DEFA14A Extra proxy material Apr 9, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2025
- DEFA14A Extra proxy material Apr 12, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2024
- DEFA14A Extra proxy material Apr 13, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 13, 2023
Ownership 8 of 817
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
Other 8 of 17
- ARS Annual report sent to shareholders Apr 10, 2026
- 424B7 Mar 6, 2026
- ARS Annual report sent to shareholders Apr 9, 2025
- UPLOAD Comment letter from SEC staff Sep 17, 2024
- CORRESP Reply to SEC staff Sep 9, 2024
- UPLOAD Comment letter from SEC staff Aug 23, 2024
- ARS Annual report sent to shareholders Apr 16, 2024
- ARS Annual report sent to shareholders Apr 13, 2023
What to read: Jun 2026 10-Q
SECSift found 2 of 13 sections worth reading, with 1 positive, 3 notable, and 2 negative flags.
Financial Statements (Item 1)
Financial statements: net income fell 23% in Q2; cash halved.Management's Discussion (Item 2)
Substantial operating details, impairment loss, leasing results, and debt maturity disclosures.PositiveNotable- Asset sales generated $432M net proceeds YTD 2026, ahead of original disposition objectives.
- Closed a $1.2B construction loan for 343 Madison after period end, cutting remaining equity need to ~$900M.
- Termination income surged to $15.7M in H1 2026 from $0.8M a year ago, a one-time gain that distorts revenue.
What changed: Jun 2026 vs. Mar 2026
About 20% of BXP's Jun 2026 10-Q is new information. 126 paragraphs were added, 264 changed, and 50 removed. Below are the most important lines SECSift identified.
New
- Entered into $1.2B construction loan for 343 Madison Avenue on July 28, 2026. Item 1
- 290 Binney Street fully placed in service in Q2 2026, 100% leased to AstraZeneca. Item 2
- 290 Binney Street placed in service on April 30, 2026. Item 1
- BXP formed a joint venture to develop a 359-unit residential project in Herndon, VA. Item 2
Changed
Removed
Everything here comes from BXP, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Aug 19, 2026, from the 10-Q for Jun 2026.